What is the role of real time PCR in the follow up of patients with chronic Chagas' disease?

[1]  T. Pumarola,et al.  Aportaciones de las técnicas moleculares en la fase crónica de la Enfermedad de Chagas en ausencia de tratamiento , 2020 .

[2]  M. Romay-Barja,et al.  The Clinical and Parasitologic Follow-up of Trypanosoma cruzi–infected Children in a Nonendemic Country , 2020, The Pediatric infectious disease journal.

[3]  M. C. Thomas,et al.  Immunological exhaustion and functional profile of CD8+ T lymphocytes as cellular biomarkers of therapeutic efficacy in chronic Chagas patients. , 2020, Acta tropica.

[4]  J. Gascón,et al.  Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays , 2018, PloS one.

[5]  I. Molina,et al.  Chagas disease , 2018, The Lancet.

[6]  M. Hoelscher,et al.  Comparison of four PCR methods for efficient detection of Trypanosoma cruzi in routine diagnostics. , 2017, Diagnostic microbiology and infectious disease.

[7]  M. Segovia,et al.  Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR , 2017, The Journal of infectious diseases.

[8]  F. Ferrer,et al.  Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[9]  M P Busch,et al.  Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity , 2015, European journal of heart failure.

[10]  M. J. Muñoz-Dávila,et al.  Risk factors and primary prevention of congenital Chagas disease in a nonendemic country. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  C. Morillo,et al.  Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. , 2013, Acta tropica.

[12]  F. Steurer,et al.  Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach , 2012, PLoS neglected tropical diseases.

[13]  O. Martins-Filho,et al.  Posttherapeutic Cure Criteria in Chagas' Disease: Conventional Serology followed by Supplementary Serological, Parasitological, and Molecular Tests , 2012, Clinical and Vaccine Immunology.

[14]  P. Chiodini,et al.  Chagas disease in European countries: the challenge of a surveillance system. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  A. Assal,et al.  International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients , 2011, PLoS neglected tropical diseases.

[16]  M. Segovia,et al.  Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. , 2010, The Journal of antimicrobial chemotherapy.

[17]  R. Favaloro,et al.  Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients , 2009, PLoS neglected tropical diseases.

[18]  R. Favaloro,et al.  Usefulness of PCR Strategies For Early Diagnosis of Chagas' Disease Reactivation and Treatment Follow‐Up in Heart Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  Rodolfo Viotti,et al.  Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment , 2006, Annals of Internal Medicine.

[20]  J. R. Cançado,et al.  Criteria of Chagas disease cure. , 1999, Memorias do Instituto Oswaldo Cruz.